Berney Discusses Increasing Venture Capital Investment in China’s Biomedical Sector

Partner Kurt Berney was quoted in the 21st Century Business Herald article, “Lilly Asia Ventures Begins Direct Investment in China-Based Pharmaceutical Enterprises.”  The article discusses the increasing number of venture capital funds in China’s biomedical sector.  In the article, Berney states that a few years ago, foreign VC funds were only waiting to see their chances in China’s biotech pharmaceutical markets; but now, the situation is undergoing some changes.  He goes on to say that an increasing number of biotech pharmaceutical companies are getting venture investments.

November 14, 2007

Related Offices

Shanghai


China
Capital Markets
Private Equity and Venture Capital